Search Results 101-110 of 16336 for Interindividual
This study will assess the safety, tolerability, pharmaokinetics, and preliminary efficacy of mosunetuzumab (Lunsumio) monotherapy in participants with relapsed ...
Inclusion Criteria: Male and/or female. Age ≥ 18 years at the time of screening. For patients aged < 20 years and enrolled in Japan, a written informed ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to develop a better blood test to diagnose early kidney injury in type 1 diabetes.
Consumer health basics. Can you remember how you got health information before the internet? Your doctor was probably your only trusted source.
Pharmacometric modeling and simulation, including assessing interindividual variability in drug distribution using population pharmacokinetics, physiologically ...
The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and ...
The purpose of this study is to evaluate changes in CSF dynamics (e.g., velocity, flow rate) between patients with normal pressure hydrocephalus and healthy ...
Mayo Clinic Laboratories.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.